SIGA Stock (NASDAQ:SIGA)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$4.31

52W Range

$4.10 - $9.62

50D Avg

$4.54

200D Avg

$6.39

Market Cap

$309.85M

Avg Vol (3M)

$612.45K

Beta

0.85

Div Yield

$0.60 (13.89%)

SIGA Company Profile


SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

46

IPO Date

Sep 10, 1997

Website

SIGA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 19
Product Sales and Supportive Services$88.05M$133.33M$11.19M
Research and Development$6.53M$5.39M$15.55M

Fiscal year ends in Dec 25 | Currency in USD

SIGA Financial Summary


Dec 25Dec 24Dec 23
Revenue$94.60M$138.72M$139.92M
Operating Income$23.70M$69.98M$83.62M
Net Income$23.30M$59.21M$68.07M
EBITDA$23.70M$70.52M$84.16M
Basic EPS$0.32$0.83$0.95
Diluted EPS$0.32$0.83$0.95

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 4:30 PM
Q3 25Nov 07, 25 | 4:30 PM
Q2 25Aug 06, 25 | 4:30 PM

Peer Comparison


TickerCompany
SNDLSNDL Inc.
EBSEmergent BioSolutions Inc.
RIGLRigel Pharmaceuticals, Inc.
DRIODarioHealth Corp.
ESPREsperion Therapeutics, Inc.
VTYXVentyx Biosciences, Inc.
AQSTAquestive Therapeutics, Inc.
OLMAOlema Pharmaceuticals, Inc.
ORGOOrganogenesis Holdings Inc.
CTMXCytomX Therapeutics, Inc.